LCTX vs TSLA · rev $2.8M vs P/E 179, rev $28.24B
Lineage Cell Therapeutics Inc (LCTX) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Latest reported TSLA revenue for 2026-06-30 was $28.24B. Net income was $1.11B. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
LCTX currently screens at market cap $213.6M. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the LCTX and TSLA stock pages for the full models.
Not investment advice.